Verbatim response from Claude
This is a common situation right now. Here are your realistic options to consider:
Compounded GLP-1s (Semaglutide)
Providers like Hims/Hers, Ro, and LifeMD offer compounded semaglutide, typically $200-$400/month. However, important caveats:
- The FDA recently ruled compounded semaglutide must be phased out (Wegovy shortage is resolving)
- Quality control varies by compounding pharmacy
- These are not FDA-approved versions
Better Alternatives to Consider First
1. Appeal your insurance denial
- Many denials are overturned on appeal
- Ask your doctor for a peer-to-peer review - this works surprisingly often
2. Novo Nordisk's savings programs
- Wegovy savings card can bring costs to ~$0-$650/month for eligible commercially insured patients
3. Try Ozempic instead
- Same drug (semaglutide), often better covered for Type 2 diabetes
- Your doctor can discuss whether this applies to your situation
4. Zepbound (tirzepatide)
- Often has different insurance criteria than Wegovy - you might qualify
- Eli Lilly offers a savings card around $550/month out of pocket
My Honest Take
Exhaust the appeal process and manufacturer savings programs before compounded versions, given the regulatory uncertainty around compounding.
Talk to your doctor about which path fits your specific situation.